Rationally modified derivatives of kisspeptin-10 (KP-10) may retain KISS1R receptor agonism while demonstrating improved metabolic stability and longer systemic exposure.
Rationally modified derivatives of kisspeptin-10 (KP-10) may retain KISS1R receptor agonism while demonstrating improved metabolic stability and longer systemic exposure.